ARTBIO AS
Developing novel alpha radioligand therapies to redefine cancer care.
Overview
- 21
- Employees
- 74.3M NOK
- Revenue
- 2018
- Founded
Description
ARTBIO is a clinical-stage radiopharmaceutical company dedicated to advancing cancer treatment through a new class of alpha radioligand therapies (ARTs). Their core mission is to develop highly effective and safe therapies by focusing on specific tumor targets combined with the optimal alpha-precurs...
Tags
Keywords
Company Information
- Industry
- Unknown
- Legal Form
- Aksjeselskap
- VAT Number
- Unknown
Decision Makers
No decision makers found yet
Similar Companies
20 similar companies in Funnelfeedr
NUCLITHERA AS
8 employeesDeveloping targeted alpha and beta emitters for metastatic cancer treatment.
ONCOINVENT SOLUTIONS AS
45 employeesNorwegian biotech transforming cancer care via direct alpha therapy.
BIO INVENTION AS
Clinical-stage company developing novel immuno-oncology antibody therapeutics for cancer.
BIOINVENT INTERNATIONAL AB
Clinical-stage biotech developing novel immuno-oncology antibody therapies for cancer.
BIOINVENT INTERNATIONAL AB
Clinical-stage biotech developing novel immuno-oncology antibody therapies for cancer.
Browse More
ARTBIO AS Questions
Want to see Funnelfeedr in action?
Book a free demo and discover how Funnelfeedr helps you find and convert your ideal customers.
Book a demo